Top Stock 4 – Quest Diagnostics (DGX)
An aging population and a greater emphasis on preventative care are creating a high-growth opportunity for Quest Diagnostics (DGX). This company is the leading provider of independent diagnostic testing in the U.S. It has built a network of more than 2,000 patient service centers across the country, offering its customers a wide array of routine and specialty laboratory tests and services.
DGX posted a nearly 25% jump in earnings for the first quarter and a significant uptick in sales that beat expectations. These are very solid results in an economic environment where most of Quest's primary customers have decided to perform more diagnostic testing in-house to cut spending.
Quest is poised for another round of great earnings, and now is the time to jump into this stock during the lull before the next quarterly reporting season.
No comments:
Post a Comment